Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Gene-Sequencing Company Illumina to Sell Cancer Test Developer

The move came two days after a court upheld the Federal Trade Commission’s challenge to the deal on antitrust grounds.

Nicole Sperling
Author: Nicole Sperling

Written by

Nicole Sperling

in

Antitrust Laws and Competition Issues, Decisions and Verdicts, European Union, Federal Trade Commission, Genetic Engineering, Grail Inc, Illumina Inc, Mergers, Acquisitions and Divestitures, Regulation and Deregulation of Industry, Tests (Medical)
←Florida Republican Party Suspends Chairman, Demands Resignation Amid Rape Investigation
Trump Says Nevada Fake Electors Treated ‘Unfairly’ During Rally In Reno→

More posts

  • Met chief accepts mistakes made over Simon Levy but defends investigation into murders

  • Paul Anthony Kelly Has Found a New Love Story as…a Disney Weddings Model

  • Venice Drama ‘I Matter’, About Roma Experience, Gets Sales Deal

  • Critical former referees add to culture of fear, says retiring Taylor

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube